These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 29702830)

  • 1. Cost-Effectiveness Analysis of Hepatitis B Immunization in Vietnam: Application of Cost-Effectiveness Affordability Curves in Health Care Decision Making.
    Tu HAT; de Vries R; Woerdenbag HJ; Li SC; Le HH; van Hulst M; Postma MJ
    Value Health Reg Issues; 2012 May; 1(1):7-14. PubMed ID: 29702830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
    Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves.
    Kim SY; Salomon JA; Goldie SJ
    Bull World Health Organ; 2007 Nov; 85(11):833-42. PubMed ID: 18038073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost-effectiveness and affordability of strategy for preventing mother-to-child transmission of hepatitis B in China].
    Lin Y; Zhang SX; Yang PC; Cai YL; Zou YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):852-859. PubMed ID: 28738455
    [No Abstract]   [Full Text] [Related]  

  • 5. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of hepatitis A vaccination in Indonesia.
    Suwantika AA; Beutels P; Postma MJ
    Hum Vaccin Immunother; 2014; 10(8):2342-9. PubMed ID: 25424941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model.
    Aggarwal R; Ghoshal UC; Naik SR
    J Hepatol; 2003 Feb; 38(2):215-22. PubMed ID: 12547411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the cost-effectiveness of universal hepatitis B virus vaccination in Iran: a Markov model analysis.
    Mokhtari AM; Barouni M; Moghadami M; Hassanzadeh J; Dewey RS; Mirahmadizadeh A
    Hum Vaccin Immunother; 2021 Jun; 17(6):1825-1833. PubMed ID: 33734949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination.
    Lee D; Park SM
    PLoS One; 2016; 11(11):e0165879. PubMed ID: 27802340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
    Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
    J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
    Krahn M; Detsky AS
    Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis.
    Yin J; Ji Z; Liang P; Wu Q; Cui F; Wang F; Liang X; Zhuang G
    Vaccine; 2015 Jul; 33(31):3731-8. PubMed ID: 26057138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries.
    Wright CM; Boudarène L; Ha NT; Wu O; Hawkins N
    BMC Public Health; 2018 Mar; 18(1):373. PubMed ID: 29558894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
    Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
    Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
    Mangen MJ; Stibbe H; Urbanus A; Siedenburg EC; Waldhober Q; de Wit GA; van Steenbergen JE;
    Vaccine; 2017 May; 35(24):3215-3221. PubMed ID: 28483198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
    Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
    Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Framework for determining the optimal course of action when efficiency and affordability measures differ by perspective in cost-effectiveness analysis-with an illustrative case of HIV treatment in Mozambique.
    Corlis J; Zhu J; Macul H; Tiberi O; Boothe MAS; Resch SC
    Cost Eff Resour Alloc; 2023 Sep; 21(1):62. PubMed ID: 37705101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique.
    Klingler C; Thoumi AI; Mrithinjayam VS
    Vaccine; 2012 Dec; 31(1):252-9. PubMed ID: 22902676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong Government perspective.
    Ho AM; Nelson EA; Walker DG
    Arch Dis Child; 2008 Jan; 93(1):52-8. PubMed ID: 17855438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of couple-based immunization strategy to prevent mother-to-child transmission of hepatitis B virus in China: A decision-analytic Markov model.
    Jing W; Liu J; Wu Y; Ma Q; Liu M
    EClinicalMedicine; 2020 Feb; 19():100264. PubMed ID: 32055793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.